Revalesio
PrivateLast Round
VC Round
Jun 9, 2022
Total Funding Raised
$14.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Revalesio operates in Healthcare & Life Sciences and is based in Tacoma, Washington. Its latest recorded funding round was a VC Round in June 2022.
Revalesio is a biotechnology company that develops anti-inflammatory therapeutic drugs designed to treat a variety of neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Revalesio Comparables
Compare Revalesio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ZZ Biotech | 84% | |
| Astrocyte Pharmaceuticals Inc. | 82% | |
| Pharmazz, Inc. | 79% |
For institutional investors. Book with your work email.
Revalesio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 9, 2022 | ||||
| VC Round | Jul 22, 2020 | ||||
| VC Round | Jun 27, 2018 | ||||
| Grant | Sep 20, 2017 | ||||
| VC Round | Jul 5, 2016 | ||||
Series B | Apr 23, 2014 |
For institutional investors. Book with your work email.
Revalesio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The ALS Association | Grant |
| Northeast ALS Consortium | Grant |
| ALS Finding a Cure | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 68% MoM.
- Jul 20, 2026
Open roles increased from 0 to 12, representing 57% of headcount.
For institutional investors. Book with your work email.
Revalesio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Revalesio's valuation, stock price, and market status.
Is Revalesio a public or private company?
Revalesio is a private company.
What is the current stock price of Revalesio?
Revalesio is a private company, so its shares have no public market price. Caplight tracks Revalesio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Revalesio worth (valuation)?
Valuation information for Revalesio is not publicly available.
Can I buy Revalesio stock?
Revalesio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Revalesio's last funding round?
Revalesio's most recent funding round was VC Round on June 9, 2022.
Who are the main investors in Revalesio?
Key investors in Revalesio include The ALS Association, Northeast ALS Consortium, ALS Finding a Cure.
Will Revalesio IPO soon?
No public IPO plans have been announced for Revalesio.
How can I track Revalesio secondary market activity?
Caplight tracks bids, offers, and trades in Revalesio's shares on secondary markets.